<?xml version="1.0"?>
<case>
<name>Medrad Inc v Alpine Medical Pty Ltd [2009] FCA 949 (25 August 2009)</name>
<AustLII>http://www.austlii.edu.au/au/cases/cth/FCA/2009/949.html</AustLII>
<citphrases>
<citphrase id="cp2.0" type=cited from="[2008] FCA 1498">patent</citphrase>
<citphrase id="cp2.1" type=cited from="[2008] FCA 1498">infringement</citphrase>
<citphrase id="cp2.2" type=cited from="[2008] FCA 1498">pharmaceutical compound</citphrase>
<citphrase id="cp2.3" type=cited from="[2008] FCA 1498">no claim for particular stereochemistry</citphrase>
<citphrase id="cp2.4" type=cited from="[2008] FCA 1498">whether racemate only claimed</citphrase>
<citphrase id="cp2.5" type=cited from="[2008] FCA 1498">whether claims covered [beta] anomer. patent</citphrase>
<citphrase id="cp2.6" type=cited from="[2008] FCA 1498">validity</citphrase>
<citphrase id="cp2.7" type=cited from="[2008] FCA 1498">pharmaceutical compound</citphrase>
<citphrase id="cp2.8" type=cited from="[2008] FCA 1498">utility</citphrase>
<citphrase id="cp2.9" type=cited from="[2008] FCA 1498">whether invention useful according to promises in patent</citphrase>
<citphrase id="cp2.10" type=cited from="[2008] FCA 1498">whether toxicity compromises utility. patent</citphrase>
<citphrase id="cp2.11" type=cited from="[2008] FCA 1498">infringement</citphrase>
<citphrase id="cp2.12" type=cited from="[2008] FCA 1498">process for manufacture of chemical compound. patent</citphrase>
<citphrase id="cp2.13" type=cited from="[2008] FCA 1498">validity</citphrase>
<citphrase id="cp2.14" type=cited from="[2008] FCA 1498">process for manufacture of chemical compound</citphrase>
<citphrase id="cp2.15" type=cited from="[2008] FCA 1498">whether invention lacked inventive step</citphrase>
<citphrase id="cp2.16" type=cited from="[2008] FCA 1498">common general knowledge</citphrase>
<citphrase id="cp2.17" type=cited from="[2008] FCA 1498">whether lack of inventive step established an interlocutory application. interlocutory injunction</citphrase>
<citphrase id="cp2.18" type=cited from="[2008] FCA 1498">alleged infringement of patent</citphrase>
<citphrase id="cp2.19" type=cited from="[2008] FCA 1498">whether prima facie case made out</citphrase>
<citphrase id="cp2.20" type=cited from="[2008] FCA 1498">whether defences of invalidity made out</citphrase>
<citphrase id="cp2.21" type=cited from="[2008] FCA 1498">necessary strength of defences on interlocutory application</citphrase>
<citphrase id="cp2.22" type=cited from="[2008] FCA 1498">whether damages an adequate remedy</citphrase>
<citphrase id="cp2.23" type=cited from="[2008] FCA 1498">balance of convenience</citphrase>
<citphrase id="cp2.24" type=cited from="[2008] FCA 1498">alleged infringer entering established market</citphrase>
<citphrase id="cp2.25" type=cited from="[2008] FCA 1498">whether possible to restore applicant to present position</citphrase>
<citphrase id="cp2.26" type=cited from="[2008] FCA 1498">relevance of apparent strength of substantive cases.</citphrase>
<citphrase id="cp3.0" type=cited from="[2007] FCA 1485">patents</citphrase>
<citphrase id="cp3.1" type=cited from="[2007] FCA 1485">application for interlocutory injunction to restrain infringement of a patent where application made for the revocation of the patent</citphrase>
<citphrase id="cp3.2" type=cited from="[2007] FCA 1485">prima facie case where patent is longstanding and has been exploited and revocation proceedings were not brought in timely fashion</citphrase>
<citphrase id="cp3.3" type=cited from="[2007] FCA 1485">where balance of convenience favours not disturbing the status quo</citphrase>
<citphrase id="cp3.4" type=cited from="[2007] FCA 1485">injunction granted</citphrase>
<citphrase id="cp4.0" type=cited from="[2006] HCA 46">australian broadcasting corporation v o'neill  defamation</citphrase>
<citphrase id="cp4.1" type=cited from="[2006] HCA 46">injunctions</citphrase>
<citphrase id="cp4.2" type=cited from="[2006] HCA 46">interlocutory injunctions</citphrase>
<citphrase id="cp4.3" type=cited from="[2006] HCA 46">interlocutory injunction to restrain publication</citphrase>
<citphrase id="cp4.4" type=cited from="[2006] HCA 46">appellant restrained from broadcasting documentary film making allegations including that respondent suspected of having committed notorious unsolved crime</citphrase>
<citphrase id="cp4.5" type=cited from="[2006] HCA 46">principles on which interlocutory injunction to restrain publication granted</citphrase>
<citphrase id="cp4.6" type=cited from="[2006] HCA 46">relevance of "flexible" or "rigid" approaches to granting interlocutory injunctions</citphrase>
<citphrase id="cp4.7" type=cited from="[2006] HCA 46">significance of value of free speech</citphrase>
<citphrase id="cp4.8" type=cited from="[2006] HCA 46">significance of avoiding "trial by media"</citphrase>
<citphrase id="cp4.9" type=cited from="[2006] HCA 46">whether relevant that only nominal damages likely to be awarded</citphrase>
<citphrase id="cp4.10" type=cited from="[2006] HCA 46">significance of status of respondent as convicted life prisoner.  injunctions</citphrase>
<citphrase id="cp4.11" type=cited from="[2006] HCA 46">interlocutory injunctions</citphrase>
<citphrase id="cp4.12" type=cited from="[2006] HCA 46">defamation</citphrase>
<citphrase id="cp4.13" type=cited from="[2006] HCA 46">whether general principles governing grant of interlocutory injunctions to restrain wrongs apply to interlocutory applications to restrain publication of allegedly defamatory matter</citphrase>
<citphrase id="cp4.14" type=cited from="[2006] HCA 46">relationship between beecham group ltd v bristol laboratories pty ltd [1968] hca 1 ; (1968) 118 clr 618 and american cyanamid co v ethicon ltd [1975] ukhl 1 ; [1975] ac 396</citphrase>
<citphrase id="cp4.15" type=cited from="[2006] HCA 46">whether respondent had made out an entitlement to an interlocutory injunction within the principles established by beecham</citphrase>
<citphrase id="cp4.16" type=cited from="[2006] HCA 46">whether full court and primary judge shown to have erred in granting of interlocutory injunction.  defamation</citphrase>
<citphrase id="cp4.17" type=cited from="[2006] HCA 46">injunctions</citphrase>
<citphrase id="cp4.18" type=cited from="[2006] HCA 46">jurisdiction to grant interlocutory injunction to restrain publication of allegedly defamatory matter</citphrase>
<citphrase id="cp4.19" type=cited from="[2006] HCA 46">nature of equitable jurisdiction to grant injunctions to restrain publication</citphrase>
<citphrase id="cp4.20" type=cited from="[2006] HCA 46">effect of common law procedure act 1854 (uk)</citphrase>
<citphrase id="cp4.21" type=cited from="[2006] HCA 46">effect of judicature act 1873 (uk).  appeal</citphrase>
<citphrase id="cp4.22" type=cited from="[2006] HCA 46">interlocutory injunction in defamation proceedings</citphrase>
<citphrase id="cp4.23" type=cited from="[2006] HCA 46">necessity of demonstrating error in order to justify intervention by high court</citphrase>
<citphrase id="cp4.24" type=cited from="[2006] HCA 46">whether error shown in approach and conclusion of full court and primary judge.  defamation</citphrase>
<citphrase id="cp4.25" type=cited from="[2006] HCA 46">defences</citphrase>
<citphrase id="cp4.26" type=cited from="[2006] HCA 46">justification</citphrase>
<citphrase id="cp4.27" type=cited from="[2006] HCA 46">whether avoiding "trial by media" relevant to determination of "public benefit" required by defamation act 1957 (tas) s 15.</citphrase>
<citphrase id="cp5.0" type=cited from="[2005] FCA 1675">patents</citphrase>
<citphrase id="cp5.1" type=cited from="[2005] FCA 1675">interlocutory injunction</citphrase>
<citphrase id="cp5.2" type=cited from="[2005] FCA 1675">application for injunction in respect of threatened infringement of patent</citphrase>
<citphrase id="cp5.3" type=cited from="[2005] FCA 1675">claim that patent invalid</citphrase>
<citphrase id="cp5.4" type=cited from="[2005] FCA 1675">lack of novelty</citphrase>
<citphrase id="cp5.5" type=cited from="[2005] FCA 1675">obviousness</citphrase>
<citphrase id="cp5.6" type=cited from="[2005] FCA 1675">lack of manner of manufacture</citphrase>
<citphrase id="cp5.7" type=cited from="[2005] FCA 1675">lack of fair basis</citphrase>
<citphrase id="cp5.8" type=cited from="[2005] FCA 1675">false suggestion</citphrase>
<citphrase id="cp5.9" type=cited from="[2005] FCA 1675">whether serious issue to be tried</citphrase>
<citphrase id="cp5.10" type=cited from="[2005] FCA 1675">whether applicants for injunction would suffer irreparable harm for which damages would not be adequate compensation unless injunction granted</citphrase>
<citphrase id="cp5.11" type=cited from="[2005] FCA 1675">balance of convenience patents</citphrase>
<citphrase id="cp5.12" type=cited from="[2005] FCA 1675">interlocutory injunction</citphrase>
<citphrase id="cp5.13" type=cited from="[2005] FCA 1675">application for injunction in respect of threatened infringement of patent</citphrase>
<citphrase id="cp5.14" type=cited from="[2005] FCA 1675">whether applicant has standing as exclusive licensee of patent</citphrase>
<citphrase id="cp6.0" type=cited from="[1968] HCA 1">injunctions</citphrase>
<citphrase id="cp6.1" type=cited from="[1968] HCA 1">patents</citphrase>
<citphrase id="cp6.2" type=cited from="[1968] HCA 1">action for infringement</citphrase>
<citphrase id="cp6.3" type=cited from="[1968] HCA 1">interlocutory injunction</citphrase>
<citphrase id="cp6.4" type=cited from="[1968] HCA 1">principles governing grant or refusal.</citphrase>
<citphrase id="cp7.0" type=citing from="[2010] FCA 38">trade practices</citphrase>
<citphrase id="cp7.1" type=citing from="[2010] FCA 38">misleading or deceptive conduct</citphrase>
<citphrase id="cp7.2" type=citing from="[2010] FCA 38">application for interim and other relief  practice and procedure</citphrase>
<citphrase id="cp7.3" type=citing from="[2010] FCA 38">interim injunction</citphrase>
<citphrase id="cp7.4" type=citing from="[2010] FCA 38">whether proof of irreparable injury is necessary in the circumstances  practice and procedure</citphrase>
<citphrase id="cp7.5" type=citing from="[2010] FCA 38">injunction sought at interlocutory stage</citphrase>
<citphrase id="cp7.6" type=citing from="[2010] FCA 38">order mandatory in character and final in form</citphrase>
<citphrase id="cp7.7" type=citing from="[2010] FCA 38">whether different standard applies  practice and procedure</citphrase>
<citphrase id="cp7.8" type=citing from="[2010] FCA 38">leave to file amended application and second further amended statement of claim  practice and procedure</citphrase>
<citphrase id="cp7.9" type=citing from="[2010] FCA 38">separate question</citphrase>
<citphrase id="cp7.10" type=citing from="[2010] FCA 38">whether premature to order a separate question to be determined  practice and procedure</citphrase>
<citphrase id="cp7.11" type=citing from="[2010] FCA 38">setting aside part of a subpoena</citphrase>
<citphrase id="cp7.12" type=citing from="[2010] FCA 38">whether documents sought are adjectivally relevant</citphrase>
</citphrases>
<citances>
<sentence id="cs0" from="[2010] FCA 38">In AB Hassle v Pharmacia (Australia) Pty Ltd (1995) 33 IPR 63 at 76-77 Ashley J remarked on a tendency to treat "irreparable harm" as a consideration going to the balance of convenience, rather than as a distinct and antecedent consideration. This approach has been reflected in some decisions of this Court: see, for example, Marley New Zealand Limited v Icon Plastics Pty Ltd [2007] FCA 851 at [3] ; Medrad Inc v Alpine Medical Pty Ltd [2009] FCA 949 ; (2009) 82 IPR 101 at [38] . </sentence>
</citances>
<legistitles>
<title id="l0">PATENTS ACT 1990 </title>
<title id="l1">PATENTS ACT 1990 - SECT 7 Novelty and inventive step</title>
<title id="l2">THERAPEUTIC GOODS ACT 1989 </title>
<title id="l3">FEDERAL COURT RULES </title>
</legistitles>
</case>